Document is current
Any future updates will be listed below
-
Authors
McCoy, Rozalina G. https://orcid.org/0000-0002-2289-3183
Mullan, Aidan F.
Jeffery, Molly M.
Bucks, Colin M.
Clements, Casey M.
Campbell, Ronna L.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497)
- License Information
-
More Information
Article History
Received: 7 February 2022
Accepted: 16 June 2022
First Online: 29 June 2022
Declarations
:
: In the last 36 months, Dr. McCoy has received unrelated support from NIDDK, PCORI, and AARP®. She also serves as a consultant to Emmi® (Wolters Kluwer) on the development of patient education materials related to prediabetes and diabetes. In the past 36 months, Dr. Jeffery has received unrelated funding from the US Food and Drug Administration; the National Heart, Lung, and Blood Institute; the National Institute on Drug Abuse; the National Center for Advancing Translational Sciences; the Agency for Healthcare Research and Quality; and the American Cancer Society. Her spouse holds shares in Goodness Growth Holdings. Dr. Clements serves as a consultant to Vail Scientific for an area unrelated to this work (sepsis). Dr. Campbell is an author for UpToDate and a consultant to Byrn Pharma for an area of unrelated to this work (anaphylaxis).
: Study contents are the sole responsibility of the authors and do not necessarily represent the official views of NIH.
Free to read: This content has been made available to all.
